254 related articles for article (PubMed ID: 18624728)
1. Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.
Jiang C; Zhao ML; Diaz M
Immunology; 2009 Jan; 126(1):102-13. PubMed ID: 18624728
[TBL] [Abstract][Full Text] [Related]
2. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.
Zan H; Zhang J; Ardeshna S; Xu Z; Park SR; Casali P
Autoimmunity; 2009 Feb; 42(2):89-103. PubMed ID: 19156553
[TBL] [Abstract][Full Text] [Related]
3. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
5. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.
Jiang C; Foley J; Clayton N; Kissling G; Jokinen M; Herbert R; Diaz M
J Immunol; 2007 Jun; 178(11):7422-31. PubMed ID: 17513793
[TBL] [Abstract][Full Text] [Related]
6. The role of activation-induced deaminase in lupus nephritis.
Diaz M
Autoimmunity; 2013 Mar; 46(2):115-20. PubMed ID: 23215788
[TBL] [Abstract][Full Text] [Related]
7. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation.
Park SR; Zan H; Pal Z; Zhang J; Al-Qahtani A; Pone EJ; Xu Z; Mai T; Casali P
Nat Immunol; 2009 May; 10(5):540-50. PubMed ID: 19363484
[TBL] [Abstract][Full Text] [Related]
8. Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity.
Jiang C; Zhao ML; Waters KM; Diaz M
Autoimmunity; 2012 Sep; 45(6):440-8. PubMed ID: 22559231
[TBL] [Abstract][Full Text] [Related]
9. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
[TBL] [Abstract][Full Text] [Related]
10. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
[TBL] [Abstract][Full Text] [Related]
11. Deficiency in activation-induced cytidine deaminase promotes systemic autoimmunity in lpr mice on a C57BL/6 background.
Chen L; Guo L; Tian J; Zheng B; Han S
Clin Exp Immunol; 2010 Feb; 159(2):169-75. PubMed ID: 19922498
[TBL] [Abstract][Full Text] [Related]
12. Enrichment of anti-glomerular antigen antibody-producing cells in the kidneys of MRL/MpJ-Fas(lpr) mice.
Sekine H; Watanabe H; Gilkeson GS
J Immunol; 2004 Mar; 172(6):3913-21. PubMed ID: 15004199
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
14. Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis.
Datta SK; Patel H; Berry D
J Exp Med; 1987 May; 165(5):1252-68. PubMed ID: 2952749
[TBL] [Abstract][Full Text] [Related]
15. Production of IgG autoantibody requires expression of activation-induced deaminase in early-developing B cells in a mouse model of SLE.
Umiker BR; McDonald G; Larbi A; Medina CO; Hobeika E; Reth M; Imanishi-Kari T
Eur J Immunol; 2014 Oct; 44(10):3093-108. PubMed ID: 25044405
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
Ning W; Cheng D; Howe PH; Bian C; Kamen DL; Luo Z; Fu X; Ogunrinde E; Yang L; Wang X; Li QZ; Oates J; Zhang W; White D; Wan Z; Gilkeson GS; Jiang W
J Autoimmun; 2022 Jul; 131():102860. PubMed ID: 35810689
[TBL] [Abstract][Full Text] [Related]
17. A new site-directed transgenic rheumatoid factor mouse model demonstrates extrafollicular class switch and plasmablast formation.
Sweet RA; Christensen SR; Harris ML; Shupe J; Sutherland JL; Shlomchik MJ
Autoimmunity; 2010 Dec; 43(8):607-18. PubMed ID: 20370572
[TBL] [Abstract][Full Text] [Related]
18. Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.
Herlands RA; William J; Hershberg U; Shlomchik MJ
Eur J Immunol; 2007 Dec; 37(12):3339-51. PubMed ID: 18034429
[TBL] [Abstract][Full Text] [Related]
19. Increased responsiveness of B. cells in the murine MRL/lpr model of lupus nephritis to interleukin-1 beta.
Lebedeva TV; Singh AK
J Am Soc Nephrol; 1995 Jan; 5(7):1530-4. PubMed ID: 7703391
[TBL] [Abstract][Full Text] [Related]
20. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM.
Boes M; Schmidt T; Linkemann K; Beaudette BC; Marshak-Rothstein A; Chen J
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1184-9. PubMed ID: 10655505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
